Kepler Cheuvreux on Friday upgraded Swedish medical technology company Getinge (GETI-B.ST) to buy from hold and increased its price target to 260 kronor from 235 kronor.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)